June 16th, 20210On Wednesday, a U.S. hospital will give the first infusion of an expensive, controversial new Alzheimer’s drug from Biogen Inc. before Medicare had even said what it will pay for — and with some doctors upset by its approval last week.
The first administration of the drug, Aduhelm, outside of a clinical trial is scheduled to take...
November 29th, 20190Rochester, Minnesota — A historic medical trial lead by Dr. Mohamad Bydon, a neurosurgeon and spine specialist at the Mayo Clinic, has yielded miraculous results for a patient who was paralyzed from the neck down due to a spinal cord injury.
Chris Barr told ABC’s Good Morning America that he had given up hope after the prognosis...
